October 2026 Recall: Updates in Immune-Based Therapies for Neurologic Disease
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
October 2026 Recall: Updates in Immune-Based Therapies for Neurologic Disease
-
ナレーター：
-
著者：
The October Recall features four previously posted episodes on immune‑based therapies for neurologic disease. In the first episode, Dr. Bhaskar Roy reviews the latest treatments, comparing their efficacy and safety. The second episode, with Dr. Michael Levy, focuses on satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy. That conversation leads into an episode with Dr. Amanda L. Piquet, who discusses the efficacy and safety of miv-cel in patients with stiff person syndrome. The episode concludes with Dr. Irene Cortese highlighting recent advances in the treatment of PML.
Podcast links:
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments
Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD
Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Article links:
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments
Safety and Efficacy of Satralizumab in Patients with Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome in a Pivotal, Multicenter, Phase 2 Study (KYSA-8)
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Disclosures can be found at Neurology.org.